Raymond A. Poot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raymond A. Poot has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Jeroen A. A. Demmers
Proteomics Center, Erasmus University Medical Center, Rotterdam, The Netherlands
9 shared publications - Debbie L. C. van Den Berg
Department of Developmental Biology, Erasmus MC-University Medical Center, 3015 GD, Rotterdam, the Netherlands
6 shared publications - Wilfred F. J. van Ijcken
Erasmus MC
6 shared publications Lize Meert
Department of Developmental Biology, Erasmus MC, Rotterdam, The Netherlands
4 shared publicationsDick H. W. Dekkers
Center for Proteomics, Erasmus MC, 3015 CN, Rotterdam, Netherlands
3 shared publicationsErik Engelen
Department of Cell Biology, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Nature Communications
Large-scale identification of the regulatory potential of SNPs in human neural stem cells
GWAS have identified thousands of SNPs associated with different human phenotypes. Most SNPs are located in non-coding regions of the genome, where a small subset of causal SNPs is thought to contribute to risk by regulating transcription. However, identification of such causal variants remains challenging due to linkage disequilibrium, where blocks of SNPs are inherited together. Here, we perform a massively parallel reporter assay called SuRE in human neural stem cells to assess the transcriptional regulatory potential of 7.1 million SNPs. We identify 7,002 SNPs with regulatory potential (emVars) among the 484,057 SNPs with sufficiently high expression. These emVars are enriched in enhancers and often coincide with binding sites for transcription factors, such as ZBTB33, YY1, and ETS factors. We overlap SuRE data with eQTL data to pinpoint likely gene-regulatory variants. Additionally, combining SuRE data with GWAS for seven neuropsychiatric phenotypes identifies 187 emVars in risk loci containing 183,186 SNPs assessed by SuRE. In conclusion, our SuRE dataset provides a rich source to prioritize genetic variants that may be relevant for complex human phenotypes.
- 3 November 2026
- Published by Springer Nature in Nature Communications
Open AccessLarge-scale identification of the regulatory potential of SNPs in human neural stem cells
GWAS have identified thousands of SNPs associated with different human phenotypes. Most SNPs are located in non-coding regions of the genome, where a small subset of causal SNPs is thought to contribute to risk by regulating transcription. However, identification of such causal variants remains challenging due to linkage disequilibrium, where blocks of SNPs are inherited together. Here, we perform a massively parallel reporter assay called SuRE in human neural stem cells to assess the transcriptional regulatory potential of 7.1 million SNPs. We identify 7,002 SNPs with regulatory potential (emVars) among the 484,057 SNPs with sufficiently high expression. These emVars are enriched in enhancers and often coincide with binding sites for transcription factors, such as ZBTB33, YY1, and ETS factors. We overlap SuRE data with eQTL data to pinpoint likely gene-regulatory variants. Additionally, combining SuRE data with GWAS for seven neuropsychiatric phenotypes identifies 187 emVars in risk loci containing 183,186 SNPs assessed by SuRE. In conclusion, our SuRE dataset provides a rich source to prioritize genetic variants that may be relevant for complex human phenotypes.
- Open Access
- 3 December 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Sperm H3K9me3 levels are associated with embryo developmental dynamics and biochemical pregnancy in IVF patients with normozoospermia
Background: The posttranslational histone modification H3K9me3 is crucial for constitutive heterochromatin (cHC) and supports genome stability and gene regulation during development. This epigenetic mark persists in human sperm post histone-to-protamine transition and is transmitted to the embryo. Although H3K9me3 variability is linked to abnormal sperm parameters, its role in fertilization and embryo development remains unclear. Given its retention in sperm, aberrant H3K9me3 levels may underlie cases of unexplained male infertility. Objective: Investigate the variability of H3K9me3 levels in sperm from normozoospermic men and assess its association with early embryo development and IVF outcomes. Material and methods: H3K9me3 and histone H3 levels were quantified by Western blot in surplus sperm from 99 normozoospermic men undergoing IVF-treatment. Patients were stratified into quartiles based on the H3K9me3/H3 ratio. Pre-implantation embryo development was assessed by time-lapse imaging, focusing on nuclear precursor body (NPB) dynamics and morphokinetics. IVF outcomes were reported as cumulative biochemical and ongoing pregnancy rates per ovum pick-up and compared across H3K9me3/H3 quartiles. Results: H3K9me3/H3 ratios exhibited substantial inter-individual variability among normozoospermic patients. Embryos from the third H3K9me3/H3 ratio quartile (Q3) demonstrated the highest proportion of zygotes with NPB clustering and faster, more consistent development through the first two cleavage divisions compared to other quartiles. A significant non-linear association was found between H3K9me3/H3 ratio and cumulative biochemical pregnancy rates: couples in the lowest quartile (Q1) had significantly reduced odds of biochemical pregnancy compared to Q3 (adjusted OR [95% CI]: 0.30 [0.09–0.97], p = 0.045). No significant association was found for ongoing pregnancy rates. Discussion and conclusions: This study reveals that sperm H3K9me3 levels vary among normozoospermic men and correlate with early embryo development and biochemical pregnancy rates following IVF. However, no significant association was found with ongoing pregnancy, suggesting that additional mechanisms may determine long-term pregnancy viability. The non-linear relationship between H3K9me3/H3 ratio and embryo development suggests an optimal range for this epigenetic mark. These findings highlight the potential influence of paternal epigenetic variation, undetectable by standard semen analysis, on embryo quality and IVF outcomes. Further studies in larger cohorts are warranted to confirm these findings and clarify underlying mechanisms.
- 3 December 2025
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Open AccessSperm H3K9me3 levels are associated with embryo developmental dynamics and biochemical pregnancy in IVF patients with normozoospermia
Background: The posttranslational histone modification H3K9me3 is crucial for constitutive heterochromatin (cHC) and supports genome stability and gene regulation during development. This epigenetic mark persists in human sperm post histone-to-protamine transition and is transmitted to the embryo. Although H3K9me3 variability is linked to abnormal sperm parameters, its role in fertilization and embryo development remains unclear. Given its retention in sperm, aberrant H3K9me3 levels may underlie cases of unexplained male infertility. Objective: Investigate the variability of H3K9me3 levels in sperm from normozoospermic men and assess its association with early embryo development and IVF outcomes. Material and methods: H3K9me3 and histone H3 levels were quantified by Western blot in surplus sperm from 99 normozoospermic men undergoing IVF-treatment. Patients were stratified into quartiles based on the H3K9me3/H3 ratio. Pre-implantation embryo development was assessed by time-lapse imaging, focusing on nuclear precursor body (NPB) dynamics and morphokinetics. IVF outcomes were reported as cumulative biochemical and ongoing pregnancy rates per ovum pick-up and compared across H3K9me3/H3 quartiles. Results: H3K9me3/H3 ratios exhibited substantial inter-individual variability among normozoospermic patients. Embryos from the third H3K9me3/H3 ratio quartile (Q3) demonstrated the highest proportion of zygotes with NPB clustering and faster, more consistent development through the first two cleavage divisions compared to other quartiles. A significant non-linear association was found between H3K9me3/H3 ratio and cumulative biochemical pregnancy rates: couples in the lowest quartile (Q1) had significantly reduced odds of biochemical pregnancy compared to Q3 (adjusted OR [95% CI]: 0.30 [0.09–0.97], p = 0.045). No significant association was found for ongoing pregnancy rates. Discussion and conclusions: This study reveals that sperm H3K9me3 levels vary among normozoospermic men and correlate with early embryo development and biochemical pregnancy rates following IVF. However, no significant association was found with ongoing pregnancy, suggesting that additional mechanisms may determine long-term pregnancy viability. The non-linear relationship between H3K9me3/H3 ratio and embryo development suggests an optimal range for this epigenetic mark. These findings highlight the potential influence of paternal epigenetic variation, undetectable by standard semen analysis, on embryo quality and IVF outcomes. Further studies in larger cohorts are warranted to confirm these findings and clarify underlying mechanisms.
- Open Access
Disruption of ADNP-KDM1A-GTF2I complex drives neural differentiation imbalance in Helsmoortel-Van der Aa syndrome
Mutations in ADNP (Activity-Dependent Neuroprotective Protein) are among the most frequent monogenic causes of autism spectrum disorder (ASD) and lead to Helsmoortel-Van der Aa syndrome (HVDAS). Yet how ADNP dysfunction leads to HVDAS is unclear. We employed patient-derived induced pluripotent stem cells, cortical organoids and ADNP KO human neural stem cells (hNSCs) to clarify the cellular and molecular mechanism of HVDAS onset. We purified an ADNP-KDM1A-GTF2I (AKG) protein complex from hNSCs and show that it targets transposable elements (TEs) to repress nearby gene transcription. Upon ADNP KO, KDM1A binding is lost at promoters targeted by AKG, pointing to ADNP as the anchoring subunit of the AKG complex. HVDAS cortical organoids show impaired progenitor proliferation and accelerated neuronal differentiation, coupled with a sustained upregulation of neurogenesis transcriptional programs, including key transcription factors normally repressed by AKG. This work suggests that the AKG complex acts as the relevant ADNP unit in the molecular onset of HVDAS.
Open AccessDisruption of ADNP-KDM1A-GTF2I complex drives neural differentiation imbalance in Helsmoortel-Van der Aa syndrome
Mutations in ADNP (Activity-Dependent Neuroprotective Protein) are among the most frequent monogenic causes of autism spectrum disorder (ASD) and lead to Helsmoortel-Van der Aa syndrome (HVDAS). Yet how ADNP dysfunction leads to HVDAS is unclear. We employed patient-derived induced pluripotent stem cells, cortical organoids and ADNP KO human neural stem cells (hNSCs) to clarify the cellular and molecular mechanism of HVDAS onset. We purified an ADNP-KDM1A-GTF2I (AKG) protein complex from hNSCs and show that it targets transposable elements (TEs) to repress nearby gene transcription. Upon ADNP KO, KDM1A binding is lost at promoters targeted by AKG, pointing to ADNP as the anchoring subunit of the AKG complex. HVDAS cortical organoids show impaired progenitor proliferation and accelerated neuronal differentiation, coupled with a sustained upregulation of neurogenesis transcriptional programs, including key transcription factors normally repressed by AKG. This work suggests that the AKG complex acts as the relevant ADNP unit in the molecular onset of HVDAS.
- Open Access
The Integrator complex prevents premature neuronal differentiation through global control of transcription elongation
Transcription pause-release constitutes a key step in the regulation of gene expression. Pathogenic variants in various pausing regulators have been identified in neurodevelopmental disorders, but how transcription pause-release regulates neural development remains largely unknown. Here we show that a patient-specific in-frame deletion in Integrator subunit 8 (INTS8) that prevents association of this subunit with the Integrator complex results in a global increase in nascent transcription and precocious expression of neuronal genes in progenitor cells. Consequently, differentiating neural progenitors fail to sustain a proliferating progenitor cell population during cortical neuronal network formation, resulting in network collapse. We show that attenuation of RNApol2 pause-release by targeted degradation of BRD4 can revert neuronal gene activation and prevent premature progenitor cell loss. Our data demonstrate that a fine-tuned balance between RNApol2 pausing and elongation is crucial for normal neuronal development and suggest transcription pause-release as a druggable target for neurological defects in developmental disorders.
Open AccessThe Integrator complex prevents premature neuronal differentiation through global control of transcription elongation
Transcription pause-release constitutes a key step in the regulation of gene expression. Pathogenic variants in various pausing regulators have been identified in neurodevelopmental disorders, but how transcription pause-release regulates neural development remains largely unknown. Here we show that a patient-specific in-frame deletion in Integrator subunit 8 (INTS8) that prevents association of this subunit with the Integrator complex results in a global increase in nascent transcription and precocious expression of neuronal genes in progenitor cells. Consequently, differentiating neural progenitors fail to sustain a proliferating progenitor cell population during cortical neuronal network formation, resulting in network collapse. We show that attenuation of RNApol2 pause-release by targeted degradation of BRD4 can revert neuronal gene activation and prevent premature progenitor cell loss. Our data demonstrate that a fine-tuned balance between RNApol2 pausing and elongation is crucial for normal neuronal development and suggest transcription pause-release as a druggable target for neurological defects in developmental disorders.
- Open Access
- 29 December 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (9) , 1497-1510
Characterization of the TBR1 interactome: variants associated with neurodevelopmental disorders disrupt novel protein interactions
TBR1 is a neuron-specific transcription factor involved in brain development and implicated in a neurodevelopmental disorder (NDD) combining features of autism spectrum disorder (ASD), intellectual disability (ID) and speech delay. TBR1 has been previously shown to interact with a small number of transcription factors and co-factors also involved in NDDs (including CASK, FOXP1/2/4 and BCL11A), suggesting that the wider TBR1 interactome may have a significant bearing on normal and abnormal brain development. Here, we have identified approximately 250 putative TBR1-interaction partners by affinity purification coupled to mass spectrometry. As well as known TBR1-interactors such as CASK, the identified partners include transcription factors and chromatin modifiers, along with ASD- and ID-related proteins. Five interaction candidates were independently validated using bioluminescence resonance energy transfer assays. We went on to test the interaction of these candidates with TBR1 protein variants implicated in cases of NDD. The assays uncovered disturbed interactions for NDD-associated variants and identified two distinct protein-binding domains of TBR1 that have essential roles in protein–protein interaction.
- 29 December 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (9) , 1497-1510
Open AccessCharacterization of the TBR1 interactome: variants associated with neurodevelopmental disorders disrupt novel protein interactions
TBR1 is a neuron-specific transcription factor involved in brain development and implicated in a neurodevelopmental disorder (NDD) combining features of autism spectrum disorder (ASD), intellectual disability (ID) and speech delay. TBR1 has been previously shown to interact with a small number of transcription factors and co-factors also involved in NDDs (including CASK, FOXP1/2/4 and BCL11A), suggesting that the wider TBR1 interactome may have a significant bearing on normal and abnormal brain development. Here, we have identified approximately 250 putative TBR1-interaction partners by affinity purification coupled to mass spectrometry. As well as known TBR1-interactors such as CASK, the identified partners include transcription factors and chromatin modifiers, along with ASD- and ID-related proteins. Five interaction candidates were independently validated using bioluminescence resonance energy transfer assays. We went on to test the interaction of these candidates with TBR1 protein variants implicated in cases of NDD. The assays uncovered disturbed interactions for NDD-associated variants and identified two distinct protein-binding domains of TBR1 that have essential roles in protein–protein interaction.
- 8 June 2022
- Published by H1 Connect
Faculty Opinions recommendation of Nonlinear control of transcription through enhancer-promoter interactions.
How enhancers act to activate transcription and which characteristics determine their strength is an important but unclear issue. Important because much of the human inter-individual variation is in the non-coding genome and often affects enhancers with unknown target genes. Defining better rules for enhancer action thereby helps understand the human genome and its variation. The results show that enhancer effects on transcription depend on interaction frequencies with the promoter, but via a non-linear relation. The authors also measure and model the effects of TAD (topologically associating domain) boundaries.
- 8 June 2022
- Published by H1 Connect
Faculty Opinions recommendation of Nonlinear control of transcription through enhancer-promoter interactions.
How enhancers act to activate transcription and which characteristics determine their strength is an important but unclear issue. Important because much of the human inter-individual variation is in the non-coding genome and often affects enhancers with unknown target genes. Defining better rules for enhancer action thereby helps understand the human genome and its variation. The results show that enhancer effects on transcription depend on interaction frequencies with the promoter, but via a non-linear relation. The authors also measure and model the effects of TAD (topologically associating domain) boundaries.
- Open Access
- 22 July 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1
Publisher Correction: Mediator complex interaction partners organize the transcriptional network that defines neural stem cells
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 22 July 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1
Open AccessPublisher Correction: Mediator complex interaction partners organize the transcriptional network that defines neural stem cells
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Open Access
- 17 June 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Mediator complex interaction partners organize the transcriptional network that defines neural stem cells
The Mediator complex regulates transcription by connecting enhancers to promoters. High Mediator binding density defines super enhancers, which regulate cell-identity genes and oncogenes. Protein interactions of Mediator may explain its role in these processes but have not been identified comprehensively. Here, we purify Mediator from neural stem cells (NSCs) and identify 75 protein-protein interaction partners. We identify super enhancers in NSCs and show that Mediator-interacting chromatin modifiers colocalize with Mediator at enhancers and super enhancers. Transcription factor families with high affinity for Mediator dominate enhancers and super enhancers and can explain genome-wide Mediator localization. We identify E-box transcription factor Tcf4 as a key regulator of NSCs. Tcf4 interacts with Mediator, colocalizes with Mediator at super enhancers and regulates neurogenic transcription factor genes with super enhancers and broad H3K4me3 domains. Our data suggest that high binding-affinity for Mediator is an important organizing feature in the transcriptional network that determines NSC identity.
- 17 June 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Open AccessMediator complex interaction partners organize the transcriptional network that defines neural stem cells
The Mediator complex regulates transcription by connecting enhancers to promoters. High Mediator binding density defines super enhancers, which regulate cell-identity genes and oncogenes. Protein interactions of Mediator may explain its role in these processes but have not been identified comprehensively. Here, we purify Mediator from neural stem cells (NSCs) and identify 75 protein-protein interaction partners. We identify super enhancers in NSCs and show that Mediator-interacting chromatin modifiers colocalize with Mediator at enhancers and super enhancers. Transcription factor families with high affinity for Mediator dominate enhancers and super enhancers and can explain genome-wide Mediator localization. We identify E-box transcription factor Tcf4 as a key regulator of NSCs. Tcf4 interacts with Mediator, colocalizes with Mediator at super enhancers and regulates neurogenic transcription factor genes with super enhancers and broad H3K4me3 domains. Our data suggest that high binding-affinity for Mediator is an important organizing feature in the transcriptional network that determines NSC identity.
- Open Access
- 28 January 2019
- Published by H1 Connect
Faculty Opinions recommendation of Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.
This article shows the surprising finding that many factors involved in transcription elongation are specifically essential for glioblastomas in vivo. Although the reason is unclear, it opens possibilities to target these resilient tumors. It also provides an interesting research track to investigate why tumor cells rely more on transcription elongation than untransformed cells and whether this dependency is different from the reliance of tumors on super enhancers, which also relate to transcription elongation.
- 28 January 2019
- Published by H1 Connect
Open AccessFaculty Opinions recommendation of Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.
This article shows the surprising finding that many factors involved in transcription elongation are specifically essential for glioblastomas in vivo. Although the reason is unclear, it opens possibilities to target these resilient tumors. It also provides an interesting research track to investigate why tumor cells rely more on transcription elongation than untransformed cells and whether this dependency is different from the reliance of tumors on super enhancers, which also relate to transcription elongation.
- 1 April 2018
- Published by Elsevier in Cell Stem Cell
- Vol. 22 (4) , 477-478
The Rules of Successful Speed Dating Are Complex, Even for Super-Enhancers
- 1 April 2018
- Published by Elsevier in Cell Stem Cell
- Vol. 22 (4) , 477-478
The Rules of Successful Speed Dating Are Complex, Even for Super-Enhancers